183 related articles for article (PubMed ID: 11920599)
1. Prediction of chemotherapeutic response by collagen gel droplet embedded culture-drug sensitivity test in human breast cancers.
Takamura Y; Kobayashi H; Taguchi T; Motomura K; Inaji H; Noguchi S
Int J Cancer; 2002 Mar; 98(3):450-5. PubMed ID: 11920599
[TBL] [Abstract][Full Text] [Related]
2. Prediction of response to docetaxel by CYP3A4 mRNA expression in breast cancer tissues.
Miyoshi Y; Ando A; Takamura Y; Taguchi T; Tamaki Y; Noguchi S
Int J Cancer; 2002 Jan; 97(1):129-32. PubMed ID: 11774254
[TBL] [Abstract][Full Text] [Related]
3. In vitro-chemosensitivity test using the collagen gel droplet embedded culture drug test (CD-DST) for malignant pleural mesothelioma: possibility of clinical application.
Higashiyama M; Oda K; Okami J; Maeda J; Kodama K; Takami K; Morinaga K; Takano T; Kobayashi H
Ann Thorac Cardiovasc Surg; 2008 Dec; 14(6):355-62. PubMed ID: 19131921
[TBL] [Abstract][Full Text] [Related]
4. The nuclear expression of poly (ADP-ribose) polymerase-1 (PARP1) in invasive primary breast tumors is associated with chemotherapy sensitivity.
Zhai L; Li S; Li X; Li H; Gu F; Guo X; Liu F; Zhang X; Fu L
Pathol Res Pract; 2015 Feb; 211(2):130-7. PubMed ID: 25480692
[TBL] [Abstract][Full Text] [Related]
5. Decreased expression of BRCA2 mRNA predicts favorable response to docetaxel in breast cancer.
Egawa C; Miyoshi Y; Takamura Y; Taguchi T; Tamaki Y; Noguchi S
Int J Cancer; 2001 Jul; 95(4):255-9. PubMed ID: 11400119
[TBL] [Abstract][Full Text] [Related]
6. [Collagen gel droplet-embedded culture drug sensitivity test in human breast cancer].
Yamamoto Y; Watanabe Y; Ishida N; Hidaka T; Sugishita H; Yoshida M; Yukumi S; Sato K; Nakagawa H; Horiuchi A; Kawachi K
Gan To Kagaku Ryoho; 2008 May; 35(5):793-6. PubMed ID: 18487915
[TBL] [Abstract][Full Text] [Related]
7. Collagen gel droplet-embedded culture-drug sensitivity test and Ki67 expression in estrogen receptor-positive and HER2-negative breast cancer.
Tozuka K; Horiguchi J; Takata D; Rokutanda N; Nagaoka R; Tokiniwa H; Kikuchi M; Satou A; Takei H; Takeyoshi I
Mol Clin Oncol; 2013 Jan; 1(1):93-99. PubMed ID: 24649129
[TBL] [Abstract][Full Text] [Related]
8. Final analysis of the prospective WSG-AGO EC-Doc versus FEC phase III trial in intermediate-risk (pN1) early breast cancer: efficacy and predictive value of Ki67 expression.
Nitz U; Gluz O; Huober J; Kreipe HH; Kates RE; Hartmann A; Erber R; Moustafa Z; Scholz M; Lisboa B; Mohrmann S; Möbus V; Augustin D; Hoffmann G; Weiss E; Böhmer S; Kreienberg R; Du Bois A; Sattler D; Thomssen C; Kiechle M; Jänicke F; Wallwiener D; Harbeck N; Kuhn W
Ann Oncol; 2014 Aug; 25(8):1551-7. PubMed ID: 24827128
[TBL] [Abstract][Full Text] [Related]
9. Prediction of chemotherapeutic effect on postoperative recurrence by in vitro anticancer drug sensitivity testing in non-small cell lung cancer patients.
Higashiyama M; Oda K; Okami J; Maeda J; Kodama K; Imamura F; Minamikawa K; Takano T; Kobayashi H
Lung Cancer; 2010 Jun; 68(3):472-7. PubMed ID: 19660825
[TBL] [Abstract][Full Text] [Related]
10. Epirubicin With Cyclophosphamide Followed by Docetaxel With Trastuzumab and Bevacizumab as Neoadjuvant Therapy for HER2-Positive Locally Advanced Breast Cancer or as Adjuvant Therapy for HER2-Positive Pathologic Stage III Breast Cancer: A Phase II Trial of the NSABP Foundation Research Group, FB-5.
Smith JW; Buyse ME; Rastogi P; Geyer CE; Jacobs SA; Patocskai EJ; Robidoux A; Conlin AK; Ansari B; Keogh GP; Stella PJ; Gross HM; Lord RS; Polikoff JA; Mauquoi C; Mamounas EP; Swain SM; Wolmark N
Clin Breast Cancer; 2017 Feb; 17(1):48-54.e3. PubMed ID: 27693116
[TBL] [Abstract][Full Text] [Related]
11. Role of Collagen Gel Droplet-Embedded Culture-Drug Sensitivity Testing (CD-DST) for Assessing the Sensitivity of Gastric Cancer to Chemotherapy Drugs Combined with Other Cancer Therapeutic Drugs.
Makino H; Nomura S; Kogo H; Wada N; Hayashi M; Yoshida H
J Nippon Med Sch; 2022 Aug; 89(4):412-421. PubMed ID: 35400719
[TBL] [Abstract][Full Text] [Related]
12. [Comparative study of chemosensitivity and efficacy between pirarubicin and epirubicin in breast cancer].
Zang MF; Zhang YM; Zhi YH; Zhai Z; Zhang M; Gu F; Zhi XC
Zhonghua Yi Xue Za Zhi; 2011 May; 91(20):1388-92. PubMed ID: 21756809
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant triweekly nanoparticle albumin-bound paclitaxel followed by epirubicin and cyclophosphamide for Stage II/III HER2-negative breast cancer: evaluation of efficacy and safety.
Shimada H; Ueda S; Saeki T; Shigekawa T; Takeuchi H; Hirokawa E; Sugitani I; Sugiyama M; Takahashi T; Matsuura K; Yamane T; Kuji I; Hasebe T; Osaki A
Jpn J Clin Oncol; 2015 Jul; 45(7):642-9. PubMed ID: 25989989
[TBL] [Abstract][Full Text] [Related]
14. Stratified phase II trial to establish the usefulness of the collagen gel droplet embedded culture-drug sensitivity test (CD-DST) for advanced gastric cancer.
Naitoh H; Yamamoto H; Murata S; Kobayashi H; Inoue K; Tani T
Gastric Cancer; 2014 Oct; 17(4):630-7. PubMed ID: 24318670
[TBL] [Abstract][Full Text] [Related]
15. Collagen gel droplet-embedded culture drug sensitivity test (CD-DST) predicts the effect of adjuvant chemotherapy on pancreatic cancer.
Ariake K; Motoi F; Mizuma M; Ohtsuka H; Hayashi H; Nakagawa K; Hata T; Mitachi K; Naitoh T; Kamei T; Unno M
Surg Today; 2019 Dec; 49(12):1035-1043. PubMed ID: 31267224
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of BRCA1 mRNA predicts favorable response to anthracycline-containing chemotherapy in breast cancers.
Egawa C; Motomura K; Miyoshi Y; Takamura Y; Taguchi T; Tamaki Y; Inaji H; Koyama H; Noguchi S
Breast Cancer Res Treat; 2003 Mar; 78(1):45-50. PubMed ID: 12611456
[TBL] [Abstract][Full Text] [Related]
17. Low LATS2 mRNA level can predict favorable response to epirubicin plus cyclophosphamide, but not to docetaxel, in breast cancers.
Takahashi Y; Miyoshi Y; Morimoto K; Taguchi T; Tamaki Y; Noguchi S
J Cancer Res Clin Oncol; 2007 Aug; 133(8):501-9. PubMed ID: 17297610
[TBL] [Abstract][Full Text] [Related]
18. Prediction of response to docetaxel by immunohistochemical analysis of CYP3A4 expression in human breast cancers.
Miyoshi Y; Taguchi T; Kim SJ; Tamaki Y; Noguchi S
Breast Cancer; 2005; 12(1):11-5. PubMed ID: 15657517
[TBL] [Abstract][Full Text] [Related]
19. p53 but not bcl-2 immunostaining is predictive of poor clinical complete response to primary chemotherapy in breast cancer patients.
Bottini A; Berruti A; Bersiga A; Brizzi MP; Brunelli A; Gorzegno G; DiMarco B; Aguggini S; Bolsi G; Cirillo F; Filippini L; Betri E; Bertoli G; Alquati P; Dogliotti L
Clin Cancer Res; 2000 Jul; 6(7):2751-8. PubMed ID: 10914720
[TBL] [Abstract][Full Text] [Related]
20. [In vitro chemosensitivity test for hepatocellular carcinoma using collagen-gel droplet embedded cultures].
Nakagawa T; Takahashi H; Kamiyama T; Nakanishi K; Takahashi M; Watanabe K; Taguchi K; Tsukahara M; Nakajima H; Kamachi H; Kurauchi N; Kamiyama N; Khor LW; Abumiya K; Matsushita M; Kobayashi H; Todo S
Gan To Kagaku Ryoho; 2004 Dec; 31(13):2145-9. PubMed ID: 15628760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
